83 related articles for article (PubMed ID: 7978838)
1. Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines.
Maiti SN; Yu M; Bueno J; Tirgari RH; Palao-Marco FL; Pulyaeva H; Thompson EW
Ann N Y Acad Sci; 1994 Sep; 732():456-8. PubMed ID: 7978838
[No Abstract] [Full Text] [Related]
2. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Yu M; Sato H; Seiki M; Thompson EW
Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
[TBL] [Abstract][Full Text] [Related]
3. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
Cowell S; Knäuper V; Stewart ML; D'Ortho MP; Stanton H; Hembry RM; López-Otín C; Reynolds JJ; Murphy G
Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
[TBL] [Abstract][Full Text] [Related]
4. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
Azzam HS; Arand G; Lippman ME; Thompson EW
J Natl Cancer Inst; 1993 Nov; 85(21):1758-64. PubMed ID: 8411260
[TBL] [Abstract][Full Text] [Related]
5. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
6. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
[TBL] [Abstract][Full Text] [Related]
7. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
8. Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines.
Polette M; Gilles C; de Bentzmann S; Gruenert D; Tournier JM; Birembaut P
Clin Exp Metastasis; 1998 Feb; 16(2):105-12. PubMed ID: 9514091
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation mediates ConA-induced membrane type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in MDA-MB-231 human breast carcinoma cells.
Yu M; Bowden ET; Sitlani J; Sato H; Seiki M; Mueller SC; Thompson EW
Cancer Res; 1997 Nov; 57(22):5028-32. PubMed ID: 9371497
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2.
Deryugina EI; Luo GX; Reisfeld RA; Bourdon MA; Strongin A
Anticancer Res; 1997; 17(5A):3201-10. PubMed ID: 9413149
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to human MMP-9.
Ramos-DeSimone N; French DL
Ann N Y Acad Sci; 1994 Sep; 732():469-71. PubMed ID: 7978841
[No Abstract] [Full Text] [Related]
12. A novel matrix-degrading protease in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Biochem Soc Trans; 1994 Feb; 22(1):49-52. PubMed ID: 8206274
[No Abstract] [Full Text] [Related]
13. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Wang F; Reierstad S; Fishman DA
Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
[TBL] [Abstract][Full Text] [Related]
14. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase.
Foda HD; George S; Conner C; Drews M; Tompkins DC; Zucker S
Lab Invest; 1996 Feb; 74(2):538-45. PubMed ID: 8780171
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 in tumor cell invasion.
French DL; Ramos-DeSimone N; Rozinski K; Nuovo GJ
Ann N Y Acad Sci; 1994 Sep; 732():324-34. PubMed ID: 7978802
[No Abstract] [Full Text] [Related]
16. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
17. MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells.
Théret N; Lehti K; Musso O; Clément B
Hepatology; 1999 Aug; 30(2):462-8. PubMed ID: 10421655
[TBL] [Abstract][Full Text] [Related]
18. Cell type-specific involvement of furin in membrane type 1 matrix metalloproteinase-mediated progelatinase A activation.
Sato T; Kondo T; Seiki M; Ito A
Ann N Y Acad Sci; 1999 Jun; 878():713-5. PubMed ID: 10415816
[No Abstract] [Full Text] [Related]
19. Epithelial-to-mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A.
Gilles C; Polette M; Piette J; Birembaut P; Foidart JM
Int J Cancer; 1994 Dec; 59(5):661-6. PubMed ID: 7960239
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-mediated regulation of matrix metalloproteinase-2 activation in normal human fibroblasts and fibrosarcoma cells.
Gervasi DC; Raz A; Dehem M; Yang M; Kurkinen M; Fridman R
Biochem Biophys Res Commun; 1996 Nov; 228(2):530-8. PubMed ID: 8920947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
